-
1
-
-
33947676929
-
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia
-
Blair M., Marczinski C.A., Davis-Faroque N., and Kertesz A. A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc 13 (2007) 237-245
-
(2007)
J Int Neuropsychol Soc
, vol.13
, pp. 237-245
-
-
Blair, M.1
Marczinski, C.A.2
Davis-Faroque, N.3
Kertesz, A.4
-
2
-
-
2942512931
-
Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis
-
Henry J.D., Crawford J.R., and Phillips L.H. Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Neuropsychologia 42 (2004) 1212-1222
-
(2004)
Neuropsychologia
, vol.42
, pp. 1212-1222
-
-
Henry, J.D.1
Crawford, J.R.2
Phillips, L.H.3
-
4
-
-
84986638429
-
Symptoms of communication breakdown in dementia: carers' perceptions
-
Powell J.A., Hale M.A., and Bayer A.J. Symptoms of communication breakdown in dementia: carers' perceptions. Eur J Disord Commun 30 (1995) 65-75
-
(1995)
Eur J Disord Commun
, vol.30
, pp. 65-75
-
-
Powell, J.A.1
Hale, M.A.2
Bayer, A.J.3
-
5
-
-
10744223443
-
Language impairment in dementia: impact on symptoms and care needs in residential homes
-
Potkins D., Myint P., Bannister C., Tadros G., Chithramohan R., Swann A., et al. Language impairment in dementia: impact on symptoms and care needs in residential homes. Int J Geriatr Psychiatry 18 (2003) 1002-1006
-
(2003)
Int J Geriatr Psychiatry
, vol.18
, pp. 1002-1006
-
-
Potkins, D.1
Myint, P.2
Bannister, C.3
Tadros, G.4
Chithramohan, R.5
Swann, A.6
-
7
-
-
69949173231
-
Alzheimer's dementia. Coping with communication decline
-
Hendryx-Bedalov P.M. Alzheimer's dementia. Coping with communication decline. J Gerontol Nurs 15 (2000) 37-47
-
(2000)
J Gerontol Nurs
, vol.15
, pp. 37-47
-
-
Hendryx-Bedalov, P.M.1
-
8
-
-
35148818907
-
Assessment of the severely impaired patient: description and validation of a new neuropsychological test battery
-
Saxton J., Swihart A.A., McGonigle-Gibson K.L., Miller V.J., and Boller F. Assessment of the severely impaired patient: description and validation of a new neuropsychological test battery. Psychol Assess 2 (1990) 298-303
-
(1990)
Psychol Assess
, vol.2
, pp. 298-303
-
-
Saxton, J.1
Swihart, A.A.2
McGonigle-Gibson, K.L.3
Miller, V.J.4
Boller, F.5
-
9
-
-
33644874628
-
Development of a short form of the Severe Impairment Battery
-
Saxton J., Kastango K.B., Hugonot-Diener L., Boller F., Verny M., Sarles C.E., et al. Development of a short form of the Severe Impairment Battery. Am J Geriatr Psychiatry 13 (2005) 999-1005
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 999-1005
-
-
Saxton, J.1
Kastango, K.B.2
Hugonot-Diener, L.3
Boller, F.4
Verny, M.5
Sarles, C.E.6
-
10
-
-
0028152357
-
Severe Impairment Battery. A neuropsychological test for severely demented patient
-
Panisset M., Roudier M., Saxton J., and Boller F. Severe Impairment Battery. A neuropsychological test for severely demented patient. Arch Neurol 51 (1994) 41-45
-
(1994)
Arch Neurol
, vol.51
, pp. 41-45
-
-
Panisset, M.1
Roudier, M.2
Saxton, J.3
Boller, F.4
-
11
-
-
0030801505
-
The Severe Impairment Battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease
-
Schmitt F.A., Ashford W., Ernesto C., Saxton J., Schneider L.S., Clark C.M., et al. The Severe Impairment Battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheimer Dis Assoc Disord 11 (1997) 51-56
-
(1997)
Alzheimer Dis Assoc Disord
, vol.11
, pp. 51-56
-
-
Schmitt, F.A.1
Ashford, W.2
Ernesto, C.3
Saxton, J.4
Schneider, L.S.5
Clark, C.M.6
-
12
-
-
69949160876
-
-
Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's patients. 2009;5:375-9.
-
(2009)
Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's patients
, vol.5
, pp. 375-379
-
-
Ferris, S.1
Ihl, R.2
Robert, P.3
Winblad, B.4
Gatz, G.5
Tennigkeit, F.6
Gauthier, S.7
-
13
-
-
15044338779
-
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like Memantine in the treatment of acute and chronic neurologic insults
-
Lipton S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like Memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1 (2004) 101-110
-
(2004)
NeuroRx
, vol.1
, pp. 101-110
-
-
Lipton, S.A.1
-
14
-
-
36048984931
-
Pharmacotherapy of Alzheimer disease
-
Seow D., and Gauthier S. Pharmacotherapy of Alzheimer disease. Can J Psychiatry 52 (2007) 620-629
-
(2007)
Can J Psychiatry
, vol.52
, pp. 620-629
-
-
Seow, D.1
Gauthier, S.2
-
15
-
-
69949164972
-
Efficacy of Memantine in patients with moderately severe to severe Alzheimer's disease in Japan (dose-finding study)
-
Homma A, Kitamura S, Yoshimura I. Efficacy of Memantine in patients with moderately severe to severe Alzheimer's disease in Japan (dose-finding study). Eur J Neurol 14.
-
Eur J Neurol
, vol.14
-
-
Homma, A.1
Kitamura, S.2
Yoshimura, I.3
-
16
-
-
34249873186
-
A 24-week randomized, controlled trial of Memantine in patients with moderate-to-severe Alzheimer disease
-
van Dyck C.H., Tariot P.N., Meyers B., and Malca Resnick E. A 24-week randomized, controlled trial of Memantine in patients with moderate-to-severe Alzheimer disease. Alzheimer Dis Assoc Disord 14 (2007) 136-143
-
(2007)
Alzheimer Dis Assoc Disord
, vol.14
, pp. 136-143
-
-
van Dyck, C.H.1
Tariot, P.N.2
Meyers, B.3
Malca Resnick, E.4
-
17
-
-
0345872128
-
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
-
Tariot P.N., Farlow M.R., Grossberg G.T., Graham S.M., McDonald S., and Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial. JAMA 291 (2004) 317-324
-
(2004)
JAMA
, vol.291
, pp. 317-324
-
-
Tariot, P.N.1
Farlow, M.R.2
Grossberg, G.T.3
Graham, S.M.4
McDonald, S.5
Gergel, I.6
-
18
-
-
0037417238
-
Memantine in moderate-to-severe Alzheimer's disease
-
Reisberg B., Doody R., Stöffler A., Schmitt F., Ferris S., and Möbius H.J. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348 (2003) 1333-1341
-
(2003)
N Engl J Med
, vol.348
, pp. 1333-1341
-
-
Reisberg, B.1
Doody, R.2
Stöffler, A.3
Schmitt, F.4
Ferris, S.5
Möbius, H.J.6
-
19
-
-
0016823810
-
"Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician
-
Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
20
-
-
0024262650
-
Functional assessment staging (FAST)
-
Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 24 (1988) 653-659
-
(1988)
Psychopharmacol Bull
, vol.24
, pp. 653-659
-
-
Reisberg, B.1
-
21
-
-
0027985334
-
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia
-
Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
-
(1994)
Neurology
, vol.44
, pp. 2308-2314
-
-
Cummings, J.L.1
Mega, M.2
Gray, K.3
Rosenberg-Thompson, S.4
Carusi, D.A.5
Gornbein, J.6
-
22
-
-
0030771116
-
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease
-
Galasko D., Bennet D., Sano M., Ernesto C., Thomas R., Grundman M., et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer Dis Assoc Disord 11 Suppl (1997) S33-S39
-
(1997)
Alzheimer Dis Assoc Disord
, vol.11
, Issue.SUPPL
-
-
Galasko, D.1
Bennet, D.2
Sano, M.3
Ernesto, C.4
Thomas, R.5
Grundman, M.6
-
23
-
-
0036047651
-
Measuring cognition in advanced Alzheimer's disease for clinical trials
-
Schmitt F.A., Cragar D., Ashford J.W., Reisberg B., Ferris S., Möbius H.J., et al. Measuring cognition in advanced Alzheimer's disease for clinical trials. J Neural Transm 62 (2002) 135-148
-
(2002)
J Neural Transm
, vol.62
, pp. 135-148
-
-
Schmitt, F.A.1
Cragar, D.2
Ashford, J.W.3
Reisberg, B.4
Ferris, S.5
Möbius, H.J.6
-
24
-
-
18844409426
-
Sufficiently important difference: expanding the framework of clinical significance
-
Barrett B., Brown D., Mundt M., and Brown R. Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making 25 (2005) 250-261
-
(2005)
Med Decis Making
, vol.25
, pp. 250-261
-
-
Barrett, B.1
Brown, D.2
Mundt, M.3
Brown, R.4
-
25
-
-
0032754432
-
Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration
-
Burback D., Molnar F.J., St John P., and Man-Son-Hing M. Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration. Dement Geriatr Cogn Disord 10 (1999) 534-540
-
(1999)
Dement Geriatr Cogn Disord
, vol.10
, pp. 534-540
-
-
Burback, D.1
Molnar, F.J.2
St John, P.3
Man-Son-Hing, M.4
-
26
-
-
33749390540
-
Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change
-
de Vet H.C., Terwee C.B., Ostelo R.W., Beckermann H., Knol D.L., and Bouter L.M. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 4 (2006) 54
-
(2006)
Health Qual Life Outcomes
, vol.4
, pp. 54
-
-
de Vet, H.C.1
Terwee, C.B.2
Ostelo, R.W.3
Beckermann, H.4
Knol, D.L.5
Bouter, L.M.6
-
27
-
-
5744242292
-
The place of Memantine in the treatment of Alzheimer's disease: a number needed to treat analysis
-
Livingston G., and Katona C. The place of Memantine in the treatment of Alzheimer's disease: a number needed to treat analysis. Int J Geriatr Psychiatry 19 (2004) 919-925
-
(2004)
Int J Geriatr Psychiatry
, vol.19
, pp. 919-925
-
-
Livingston, G.1
Katona, C.2
|